- Home
- ELVN vs LU Comparison
ELVN vs LU Comparison
Compare ELVN & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | LU |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ELVN | LU |
|---|---|---|
| Price | $41.49 | $1.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $43.40 | $2.00 |
| AVG Volume (30 Days) | 925.8K | ★ 930.1K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $1.73 |
| 52 Week High | $48.53 | $4.57 |
Technical Indicators
Market Signals| Indicator | ELVN | LU |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 48.49 |
| Support Level | $16.84 | $1.73 |
| Resistance Level | $48.53 | $2.77 |
| Average True Range (ATR) | 2.29 | 0.08 |
| MACD | -0.97 | 0.02 |
| Stochastic Oscillator | 17.12 | 36.21 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.